These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

103 related items for PubMed ID: 7524305

  • 1. Prostate-specific antigen. Current role in diagnostic pathology of prostate cancer.
    Bostwick DG.
    Am J Clin Pathol; 1994 Oct; 102(4 Suppl 1):S31-7. PubMed ID: 7524305
    [Abstract] [Full Text] [Related]

  • 2. Androgen receptor expression in prostate cancer lymph node metastases is predictive of outcome after surgery.
    Sweat SD, Pacelli A, Bergstralh EJ, Slezak JM, Cheng L, Bostwick DG.
    J Urol; 1999 Apr; 161(4):1233-7. PubMed ID: 10081876
    [Abstract] [Full Text] [Related]

  • 3. The role of prostate-specific antigen in the chemoprevention of prostate cancer.
    Crawford ED, DeAntoni EP, Ross CA.
    J Cell Biochem Suppl; 1996 Apr; 25():149-55. PubMed ID: 9027612
    [Abstract] [Full Text] [Related]

  • 4. Preoperative serum prostate specific antigen levels between 2 and 22 ng./ml. correlate poorly with post-radical prostatectomy cancer morphology: prostate specific antigen cure rates appear constant between 2 and 9 ng./ml.
    Stamey TA, Johnstone IM, McNeal JE, Lu AY, Yemoto CM.
    J Urol; 2002 Jan; 167(1):103-11. PubMed ID: 11743285
    [Abstract] [Full Text] [Related]

  • 5. Perineural invasion and seminal vesicle involvement predict pelvic lymph node metastasis in men with localized carcinoma of the prostate.
    Stone NN, Stock RG, Parikh D, Yeghiayan P, Unger P.
    J Urol; 1998 Nov; 160(5):1722-6. PubMed ID: 9783940
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Reverse transcriptase polymerase chain reaction for prostate specific antigen in the management of prostate cancer.
    Gomella LG, Raj GV, Moreno JG.
    J Urol; 1997 Aug; 158(2):326-37. PubMed ID: 9224297
    [Abstract] [Full Text] [Related]

  • 8. The role of P501S and PSA in the diagnosis of metastatic adenocarcinoma of the prostate.
    Sheridan T, Herawi M, Epstein JI, Illei PB.
    Am J Surg Pathol; 2007 Sep; 31(9):1351-5. PubMed ID: 17721190
    [Abstract] [Full Text] [Related]

  • 9. [Adenocarcinoma of the prostate].
    Dvorácek J.
    Cas Lek Cesk; 1998 Aug 31; 137(17):515-21. PubMed ID: 9787503
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Prostate-specific membrane antigen expression as a predictor of prostate cancer progression.
    Perner S, Hofer MD, Kim R, Shah RB, Li H, Möller P, Hautmann RE, Gschwend JE, Kuefer R, Rubin MA.
    Hum Pathol; 2007 May 31; 38(5):696-701. PubMed ID: 17320151
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Is preoperative serum prostate-specific antigen level significantly related to clinical recurrence after radical retropubic prostatectomy for localized prostate cancer?
    Haukaas SA, Halvorsen OJ, Daehlin L, Hostmark J, Akslen LA.
    BJU Int; 2006 Jan 31; 97(1):51-5. PubMed ID: 16336328
    [Abstract] [Full Text] [Related]

  • 15. Heat shock protein expression independently predicts clinical outcome in prostate cancer.
    Cornford PA, Dodson AR, Parsons KF, Desmond AD, Woolfenden A, Fordham M, Neoptolemos JP, Ke Y, Foster CS.
    Cancer Res; 2000 Dec 15; 60(24):7099-105. PubMed ID: 11156417
    [Abstract] [Full Text] [Related]

  • 16. Biopsy indication--a predictor of pathologic stage among men with preoperative serum PSA levels of 4.0 ng/mL or less and T1c disease.
    Freedland SJ, Mangold LA, Epstein JI, Partin AW.
    Urology; 2004 May 15; 63(5):887-91. PubMed ID: 15134972
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Prostate specific antigen velocity in men with total prostate specific antigen less than 4 ng/ml.
    Loeb S, Roehl KA, Nadler RB, Yu X, Catalona WJ.
    J Urol; 2007 Dec 15; 178(6):2348-52; discussion 2352-3. PubMed ID: 17936844
    [Abstract] [Full Text] [Related]

  • 19. Detection of prostatic carcinoma: the role of TRUS, TRUS guided biopsy, digital rectal examination, PSA and PSA density.
    Men S, Cakar B, Conkbayir I, Hekimoglu B.
    J Exp Clin Cancer Res; 2001 Dec 15; 20(4):473-80. PubMed ID: 11876539
    [Abstract] [Full Text] [Related]

  • 20. [Prostate-specific antigen].
    Eide IA, Angelsen A.
    Tidsskr Nor Laegeforen; 2000 Sep 10; 120(21):2528-31. PubMed ID: 11070990
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.